therapy

Miltenyi Biotec Receives ‘Special Recognition Award’ for Pioneering Work in Cell & Gene Therapy at BioSpectrum India Excellence Awards 2025

NEW DELHI, Dec. 9, 2025 /PRNewswire/ -- Miltenyi Biotec has been honoured with the Special Recognition Award for Pioneering Work…

2 days ago

Elekta showcases Evo, its AI-powered, online adaptive CT-Linac at the Association of Medical Physicists of India – National Congress 2025 (AMPICON) in Guwahati

Evo features high-definition image quality and online adaptive radiotherapy capabilities for treating cancerGUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta…

1 week ago

Vantive partners with IDBS to drive global digital transformation in vital organ therapy

WOKING, United Kingdom, Dec. 2, 2025 /PRNewswire/ -- IDBS, a Danaher company and leading provider of cloud-based data management software…

2 weeks ago

TAP Sleep Care Secures Full Medicare Portfolio Coverage: Nylon flexTAP Receives PDAC Approval under E0486

December 01, 2025 12:10 ET  | Source: Airway Management, Inc. DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Airway Management, the…

2 weeks ago

CQ Medical Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition

AVONDALE, Pa., Dec. 1, 2025 /PRNewswire/ -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud…

2 weeks ago

Advanced Radiotherapy is a game-changer for India’s cancer care burden

MUMBAI, India, Nov. 27, 2025 /PRNewswire/ -- In a country with over 1.4 million[i] cases reported annually, with most being…

3 weeks ago

KL Rahul Gets Candid on Therapy, Criticism and Life Beyond Cricket in Humans of Bombay's New Show 'Like an Athlete'

Humans of Bombay launches its latest original production, Like an Athlete, kicking off with none other than KL Rahul, one…

1 month ago

uniQure to Announce Third Quarter 2025 Financial Results

LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing…

1 month ago

Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa

DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…

1 month ago

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic…

1 month ago